Conference Program Home
  My Program

All Times EDT

Abstract Details

Activity Number: 481 - Dose Finding, Dose Selection, and Early-Phase Trials
Type: Contributed
Date/Time: Wednesday, August 10, 2022 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #322506
Title: Machine Learning in Pharmacogenomics
Author(s): Jackson Lautier and Junghi Kim and Jessica Kim* and Stella Grosser
Companies: University of Connecticut and Food and Drug Administration (FDA) and U.S. Food and Drug Administration and U.S. Food and Drug Administration
Keywords: PK profiles; clustering; Pharmacogenetics; dosage recommendation; precision medicine
Abstract:

Pharmaceutical researchers are continually searching for techniques to improve both processes and patient outcomes. An area of recent interest is the potential for machine learning applications within pharmacology. One such application is the unsupervised clustering of pharmacokinetic (PK) profiles, by considering a PK profile as a time series object. We review hierarchical clustering within the context of clustering PK profiles, and find it to be effective at clustering PK profiles and informative via the resulting data visualization of a dendrogram. We scrutinize measures of dissimilarity between time series objects to identify Euclidean distance for clustering PK profiles. We further find dynamic time warping, Fréchet, and structure-based measures of dissimilarity, then use subject level data from a new drug application as a case study to demonstrate how unsupervised clustering of PK profiles can be useful in helping to identify genetic factors known to cause inter-individual differences in pharmacokinetics. Such information may be used in the determination of individualized therapeutic strategies or appropriate dosages, known more broadly as precision medicine.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2022 program